Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update
Avicannas evidence-based pathway for cannabinoid-based medicine aligns with the executive order.
Avicannas 2025 advances across R&D, clinical development, and medical affairs.
TORONTO, Dec. 19,…